Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions
by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and
Updated on: July 17,2024
0

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions
by Xia & He PublishingICI, immune checkpoint inhibitor. Credit: Jian-Hong Zhong, Liang Ma, Le Li, Zhen-Zhen LiHepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and
Updated on:July 17,2024
0
